{"id":"NCT02085161","sponsor":"Boehringer Ingelheim","briefTitle":"To Evaluate the Effect of Inhaled Medication Together With Exercise and Activity Training on Exercise Capacity and Daily Activities in Patients With Chronic Lung Disease With Obstruction of Airways","officialTitle":"An Exploratory, 12 Week, Randomised, Partially Double-blinded, Placebo-controlled Parallel Group Trial to Explore the Effects of Once Daily Treatments of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination or Tiotropium (Both Delivered by Respimat® Inhaler), Supervised Exercise Training and Behavior Modification on Exercise Capacity and Physical Activity in Patients With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-03","primaryCompletion":"2015-08","completion":"2015-10","firstPosted":"2014-03-12","resultsPosted":"2017-01-06","lastUpdate":"2017-01-06"},"enrollment":304,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Pulmonary Disease, Chronic Obstructive"],"interventions":[{"type":"DRUG","name":"placebo to tiotropium + olodaterol","otherNames":[]},{"type":"DRUG","name":"tiotropium+olodaterol","otherNames":[]},{"type":"DRUG","name":"tiotropium +olodaterol","otherNames":[]},{"type":"DRUG","name":"tiotropium","otherNames":[]}],"arms":[{"label":"placebo","type":"PLACEBO_COMPARATOR"},{"label":"tiotropium + olodaterol high dose with BM","type":"EXPERIMENTAL"},{"label":"tiotropium","type":"ACTIVE_COMPARATOR"},{"label":"tiotropium + olodaterol with exercise training and BM","type":"EXPERIMENTAL"}],"summary":"The primary objectives of the study are to explore the effect of treatment with orally inhaled tiotropium + olodaterol fixed dose combination with and without exercise training, and tiotropium comparing to placebo, on top of behavioural modification in improving exercise capacity in patients with COPD","primaryOutcome":{"measure":"Endurance Time During Endurance Shuttle Walk Test (ESWT) to Symptom Limitation After 8 Weeks","timeFrame":"Week 8","effectByArm":[{"arm":"Placebo With Behavioural Modification (BM)","deltaMin":244.07,"sd":17.666},{"arm":"Tiotropium (Tio) 5 Micro-grams (μg) With BM","deltaMin":254.18,"sd":18.099},{"arm":"Tiotropium + Olodaterol (Olo) (5/5 μg) FDC With BM","deltaMin":315.32,"sd":21.671},{"arm":"Tio+Olo (5/5 μg) FDC With Exercise Training (ET) and BM","deltaMin":355.73,"sd":24.787}],"pValues":[{"comp":"OG000 vs OG003","p":"0.0002"},{"comp":"OG000 vs OG002","p":"0.0109"},{"comp":"OG000 vs OG001","p":"0.6895"},{"comp":"OG002 vs OG003","p":"0.2188"},{"comp":"OG001 vs OG002","p":"0.0303"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":26},"locations":{"siteCount":34,"countries":["United States","Australia","Austria","Belgium","Canada","Denmark","Germany","New Zealand","Poland","Portugal","United Kingdom"]},"refs":{"pmids":["27075841","27044576"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":75},"commonTop":["Chronic obstructive pulmonary disease","Nasopharyngitis","Dyspnoea","Back pain"]}}